AUGMENTIN syrup - Medsafe
1 AUGMENTIN syrup Potassium clavulanate/amoxicillin trihydrate equivalent to 31.25 mg clavulanic acid/125 mg amoxicillin Potassium clavulanate/amoxicillin trihydrate ...
Download AUGMENTIN syrup - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
O que é um medicamento O que é o RNI? anticoagulante? …
cardiol.brO que é um medicamento anticoagulante? São medicamentos utilizados para deixar o sangue mais “ralo”, como a varfarina ( Marevan ®, Coumadin®, Marfarin , Warfarin®
QUESTIONÁRIO PARA MARCAÇÃO DE EXAMES
endoview.med.brQUESTIONÁRIO PARA MARCAÇÃO DE EXAMES Preencha o questionário abaixo e entregue na recepção da Endoview ou envie para o email: colonoscopia@endoview.med.br Entraremos em contato em até 3 dias úteis para agendar seu exame.Caso isso não ocorra, entre em contato conosco (3527-6001).Nome: CPF:
Ohjeistus antikoagulanttihoidon seurantaan ja ...
tepatampere.fiSyventävä tieto: käytettävät lääkkeet: varfariini (MarevanR) • Jos lääkeannos unohtuu, sen voi ottaa seuraavana päivänä • Luontaistuotteet voivat vaikutta Marevan hoidon tasapainoon
Nationale retningslinier for intravenøs ...
www.dsfa.dk! 3! 1. Baggrund og medlemmer af arbejdsgruppen I 2007 anmodede Sundhedsstyrelsen om nedsættelse af en arbejdsgruppe med henblik på udarbejdelse af ”Nationale retningslinier for intravenøs
AUGMENTIN tablets - Medsafe
www.medsafe.govt.nz2 AUGMENTIN during breastfeeding. You are taking any other medicines or herbal remedies. AUGMENTIN is not addictive. AUGMENTIN does not usually
Nieuwe Orale AntiCo (NOAC) SINT-ANDRIES TIELT
www.sintandriestielt.beNieuwe Orale AntiCo (NOAC) – SINT-ANDRIES TIELT Vormen Terugbetaling VKF Keuze Kunstklep Valvulaire VKF CI voor NOAC VKA ® Eliquis® + ≥ 2: lftd ≥ 80 j / G ≤ 60 kg / creat > 1,5 mg / GFR 15-30